X0508 4 2025-08-12 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001644087 Donovan Joanne M. C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET BOULDER CO 80301 false true false false CMO false Common Stock 2025-08-12 4 M false 5781.00 0.00 A 28223.00 D Common Stock 2025-08-12 4 S false 2862.00 13.3924 D 25361.00 D Restricted Stock Units 0.00 2025-08-12 4 M false 5781.00 0.00 D 2034-08-12 Common Stock 5781.00 17344.00 D Restricted Stock Units 0.00 2025-08-12 4 A false 28125.00 0.00 A 2035-08-12 Common Stock 28125.00 28125.00 D Stock Option (Right to Buy) 13.39 2025-08-12 4 A false 168750.00 0.00 A 2035-08-12 Common Stock 168750.00 168750.00 D Includes 854 shares purchased on May 15, 2025 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $13.36 to $13.49, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2025. Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2026. 1/48th of the shares subject to the option vest each month beginning on September 12, 2025, subject to the Reporting Person continuing as a service provider through each vest date. John R. Moore Attorney-in-Fact for Donovan Joanne M. 2025-08-14